• If you are citizen of an European Union member nation, you may not use this service unless you are at least 16 years old.

  • You already know Dokkio is an AI-powered assistant to organize & manage your digital files & messages. Very soon, Dokkio will support Outlook as well as One Drive. Check it out today!



Page history last edited by PBworks 18 years, 8 months ago




The aim of treatment is to suppress disease activity and preserve joint function in the Inflammatory Arthropathies.


DOSAGE - As advised by Rheumatologist :


10 mg, doubling to 20 mg after 8 weeks unless significant improvement in disease.

or (in the elderly, frail or very thin)

7.5 mg as a single dose once weekly, doubling to 15mg after 3 months, and increasing by 5mg every 3 months thereafter until a maximum of 25mg weekly, if lower doses ineffective.


Folic Acid 5 mg should be prescribed once weekly, taken the day after the Methotrexate dose. This reduces adverse effects.



FBC, ESR AND LFT fortnightly until 6 weeks after last dose increase, then monthly

U&Es - 6-12 monthly

withhold and inform Rheumatology Department if any of the following:


Neutrophils < 2.0 x 109/l

Platelets < 150 x 109/l

> 2 fold increase in AST, ALT (from upperlimit)

Unexplained fall in Albumin

Rash or oral ulceration

New or increasing dyspnoea or cough

MCV > 105


Significant deterioration in renal function - reduce dose

Abnormal bruising or sore throat - withhold until FBC available

Duration of Treatment and Time to Response

Treatment is continued indefinitely providing it remains effective and there are no significant side effects. Methotrexate takes about 2-3 months to become effective. During this period there are likely to be continued symptoms or signs of disease activity. it is reasonable to use IM Depo Steroid (Kenalog 40 mg or Depo Medrone 80 mg) up to monthly, depending on the requirements of the individual patient. The dose required is small (eg monthly Kenalog 40 mg = 1.6 mg Prednisolone daily). If IM steroids are still required three months after starting treatment the Methotrexate should be increased.



Unfortunately disease modifying drugs will not prevent all flares. These can be managed with IM Depo Steroid as outlined above. If flares become more frequent, or the disease fails to settle between flares, the dosage should be increased, or an alternative discussed with the Rheumatologist.



Known hypersensitivity to Methotrexate. Alcoholism, severe renal, hepatic or haematological impairment. Immunodeficiency, pregnancy, breast feeding, live vaccines, co-prescription of folate antagonists eg Co-trimoxazole.




Caution in renal impairment, peptic ulcer, ulcerative colitis, ulcerative stomatitis, diarrhoea, debility. Avoid conception for six months after treatment stops. Patients should be cautioned to contact GP immediately if they develop a cough or dyspnoea. Treatment should be interrupted if there is marked GI upset usually severe stomatitis.




Methotrexate excretion may be affected but actual toxicity is exceedingly rare when co-prescribed with salicylates, sulphonamides (including Trimethoprim), diuretics, hypoglycaemics, diphenylhydantoins, tetracyclines, Chloramphenicol, P-aminobenzoic acid and NSAIDs.



Side effects



Mucocutaneous - urticaria, erythematous, purritis, alopecia, severe or increasing

oral ulceration


Haematological - neutropenia, thrombocytopenia and rarely aplastic anaemia


Gastrointestinal - GI UPSET, enteritis


Other - acute tubular necrosis, interstitial pneumonitis, liver fibrosis,

depression, irritability

Comments (0)

You don't have permission to comment on this page.